Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Use of benzodiazepines to control disruptive behavior in inpatients.

Salzman C.

J Clin Psychiatry. 1988 Dec;49 Suppl:13-5. Review.

PMID:
3058683
2.

Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.

Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, Thayer S.

J Clin Psychiatry. 1991 Apr;52(4):177-80.

PMID:
1673123
4.

Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.

Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, Gharabawi GM.

J Clin Psychiatry. 2004 Mar;65(3):386-94.

PMID:
15096079
5.

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L, Dubin W, McGlynn C, Goodman L.

Am J Emerg Med. 1997 Jul;15(4):335-40.

PMID:
9217519
6.

A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.

Bieniek SA, Ownby RL, Penalver A, Dominguez RA.

Pharmacotherapy. 1998 Jan-Feb;18(1):57-62.

PMID:
9469682
7.

Atypical antipsychotic medications in the psychiatric emergency service.

Currier GW.

J Clin Psychiatry. 2000;61 Suppl 14:21-6. Review.

8.

Benzodiazepines combined with neuroleptics for management of severe disruptive behavior.

Salzman C, Green AI, Rodriguez-Villa F, Jaskiw GI.

Psychosomatics. 1986 Jan;27(1 Suppl):17-22. No abstract available.

PMID:
3952250
9.

Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.

Garza-TreviƱo ES, Hollister LE, Overall JE, Alexander WF.

Am J Psychiatry. 1989 Dec;146(12):1598-601.

PMID:
2686478
10.

Lorazepam for the treatment of psychotic agitation.

Ward ME, Saklad SR, Ereshefsky L.

Am J Psychiatry. 1986 Sep;143(9):1195-6. No abstract available.

PMID:
3752309
11.

Psychopharmacology in psychiatric emergencies.

Extein I.

Int J Psychiatry Med. 1980-1981;10(3):189-204. Review.

PMID:
6108296
12.

Droperidol vs. haloperidol in the initial management of acutely agitated patients.

Resnick M, Burton BT.

J Clin Psychiatry. 1984 Jul;45(7):298-9.

PMID:
6376480
13.

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP.

J Clin Psychiatry. 2001 Jan;62(1):12-8. Erratum in: J Clin Psychiatry 2001 Mar;62(3):209.

PMID:
11235922
14.

Best clinical practice with ziprasidone IM: update after 2 years of experience.

Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R.

CNS Spectr. 2005 Sep;10(9):1-15. Review.

PMID:
16247923
15.

Olanzapine for injection: new formulation. No advantage in agitated patients.

[No authors listed]

Prescrire Int. 2004 Jun;13(71):92-3.

PMID:
15233144
16.

Managing the agitated psychotic patient: a reappraisal of the evidence.

Allen MH.

J Clin Psychiatry. 2000;61 Suppl 14:11-20. Review.

17.

Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting.

Foster S, Kessel J, Berman ME, Simpson GM.

Int Clin Psychopharmacol. 1997 May;12(3):175-9.

PMID:
9248875
18.

A review of agitation in mental illness: treatment guidelines and current therapies.

Marder SR.

J Clin Psychiatry. 2006;67 Suppl 10:13-21. Review.

19.

[Rapid tranquillisation; review of the literature and recommendations].

Bak M, van Os J, Marcelis M.

Tijdschr Psychiatr. 2011;53(10):727-37. Review. Dutch.

20.

Supplemental Content

Support Center